Company Analysis

Cue Biopharma, Inc. (CUE)

Nasdaq: CUE · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2015
Grade4.8
◀ Past 4.0● Present 4.0▶ Future 6.7
1 est.

Who runs Cue Biopharma, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Lin Shao-Lee
Chief Executive Officer. First filing May 2026, latest Oct 14, 2026, 2 filings in all.
Officers reporting now
9
of 17 people with a filing in the last fifteen months
Directors reporting now
8
36 people on the record since 2017
Officerssales are open-market, Oct 14, 2025 to Oct 14, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Lin Shao-LeeChief Executive OfficerMay 2026Oct 14, 20267 · $1.9M
Ray SumitaChief Legal Compliance OfficerJun 2026Oct 14, 20264 · $300,000
Meluzio Michael VincentVP, Prin. Accounting OfficerJun 2026Oct 14, 20264 · $200,000
Ahlers James MChief Financial OfficerJul 2026Aug 3, 2026none
Borie Dominique ChristianChief Medical OfficerJul 2026Jul 15, 2026none
Baker Daniel G.CHIEF DEVELOPMENT OFFICERNov 2024Apr 10, 2026none
Warren LucindaCHIEF BUSINESS OFFICERSep 2024Apr 10, 2026none
Sandercock ColinSVP, GENERAL COUNSELDec 2017Apr 10, 2026none
Azam UsmanCHIEF EXECUTIVE OFFICEROct 2025Oct 2, 2025none
Directorssales are open-market, Oct 14, 2025 to Oct 14, 2026
NameRoleFirst filingLatest filingSales, 12 months
Garzone PameladirectorApr 2023Aug 28, 2026none
Sarraf PashadirectorMar 2025Aug 28, 2026none
Camardo Daniel A.directorJun 2026Jul 10, 2026none
Meehan Viola MongdirectorJun 2026Jul 10, 2026none
Broadfoot Jill MariedirectorJun 2025Jan 6, 2026none
Kiener Peter AdirectorDec 2017Jan 6, 2026none
Morich FrankdirectorAug 2018Jan 6, 2026none
Verheyen PatrickdirectorApr 2023Jan 6, 2026none
Earlier names on the record19, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CUE · research, not advice